Vitamins: Global Strategic Business Report

Global Vitamins Market to Reach $11.3 Billion by 2030

The global market for Vitamins estimated at US$7.4 Billion in the year 2022, is projected to reach a revised size of US$11.3 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2022-2030. Vitamin B, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$4.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Vitamin E segment is readjusted to a revised 4.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 10% CAGR

The Vitamins market in the U.S. is estimated at US$2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 10% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Select Competitors (Total 198 Featured) -

• ADISSEO France S.A.S
• Archer Daniels Midland Company
• BASF SE
• Btsa Biotecnologias Aplicadas AS
• Farbest Brands
• Glanbia PLC
• Lonza Group Ltd.
• Rabar Pty., Ltd.
• Royal DSM NV
• Showa Denko K.K.
• SternVitamin GmbH & Co. KG
• The Wright Group
• Vitablend Nederland B.V.
• Watson, Inc.
• Zagro Asia Ltd.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year